MedPath

Effect of Nigella sativa seed oil in treatment of non-alcoholic fatty liver disease

Not Applicable
Conditions
on-alcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT20090804002288N13
Lead Sponsor
Iranian academic center for education culture and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients whose hepatic sonography shows they have fatty liver disease
Age of 20 to 70 years

Exclusion Criteria

Child-Pugh score above 7
Hepatic disease other than non-alcoholic fatty liver disease
Pregnant women
Women planning pregnancy
Lactating women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatty liver grade. Timepoint: Before intervention and 3 month? after intervention. Method of measurement: Liver sonography.;Blood level of ALT. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Medical laboratory (kit).;Blood level of AST. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Medical laboratory (kit).;Blood level of LDL-C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Medical laboratory (kit).;Blood level of triglyceride. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Medical laboratory (kit).
Secondary Outcome Measures
NameTimeMethod
Blood level of HDL-C. Timepoint: Before intervention and 3 month after intervention. Method of measurement: Medical laboratory (kit).
© Copyright 2025. All Rights Reserved by MedPath